Possis Medical, Inc. Continues Expansion Of Its Product Line, Adding A New Thrombectomy Catheter To The Spiroflex(R) Family

MINNEAPOLIS--(BUSINESS WIRE)--July 31, 2006--Possis Medical, Inc. (NASDAQ:POSS - News) today announced market release of the AngioJet® Spiroflex®VG Rheolytic(TM) Thrombectomy catheter. The new Spiroflex VG Catheter provides over twice the clot removing power compared to the Company’s 4 French XMI® and Spiroflex catheters and it is the first AngioJet catheter of its size to be offered in a Rapid Exchange platform.